相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Prognostic effect of programmed death-ligand 1 (PD-L1) in ovarian cancer: a systematic review, meta-analysis and bioinformatics study
Lin Wang
JOURNAL OF OVARIAN RESEARCH (2019)
Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries
Claudia Allemani et al.
LANCET (2018)
Inhibition of IL-6-JAK/Stat3 signaling in castration-resistant prostate cancer cells enhances the NK cell-mediated cytotoxicity via alteration of PD-L1/NKG2D ligand levels
Lijun Xu et al.
MOLECULAR ONCOLOGY (2018)
Inflammatory cytokines IL-17 and TNF-α up-regulate PD-L1 expression in human prostate and colon cancer cells
Xun Wang et al.
IMMUNOLOGY LETTERS (2017)
The Association of Peripheral Blood Regulatory T-Cell Concentrations With Epithelial Ovarian Cancer A Brief Report
Rikki A. Cannioto et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2017)
Membranous and Cytoplasmic Expression of PD-L1 in Ovarian Cancer Cells
Qiu-Xia Qu et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
IL17 producing γδT cells induce angiogenesis and are associated with poor survival in gallbladder cancer patients
Rushikesh Sudam Patil et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
PD-1/PD-L1 blockade in cancer treatment: perspectives and issues
Junzo Hamanishi et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2016)
The EGFR pathway is involved in the regulation of PD-L1 expression via the IL-6/JAK/STAT3 signaling pathway in EGFR-mutated non-small cell lung cancer
Nan Zhang et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
IFN-γ from lymphocytes induces PD-L1 expression and promotes progression of ovarian cancer
K. Abiko et al.
BRITISH JOURNAL OF CANCER (2015)
Chemotherapy Induces Programmed Cell Death-Ligand 1 Overexpression via the Nuclear Factor-κB to Foster an Immunosuppressive Tumor Microenvironment in Ovarian Cancer
Jin Peng et al.
CANCER RESEARCH (2015)
Modulation of STAT3 and STAT5 activity rectifies the imbalance of Th17 and Treg cells in patients with acute coronary syndrome
Yingxia Zheng et al.
CLINICAL IMMUNOLOGY (2015)
Decreased expression of IL-27 and its correlation with Th1 and Th17 cells in progressive multiple sclerosis
Shao-can Tang et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2015)
Decreased IL-27 Negatively Correlated with Th17 Cells in Non-Small-Cell Lung Cancer Patients
Minchao Duan et al.
MEDIATORS OF INFLAMMATION (2015)
Th17 cells and interleukin-17 increase with poor prognosis in patients with acute myeloid leukemia
Yixiang Han et al.
CANCER SCIENCE (2014)
Development and function of interleukin 17-producing γδ T cells
Thomas Korn et al.
YEAR IN IMMUNOLOGY (2012)
Expression of Th17 Cells in Breast Cancer Tissue and Its Association with Clinical Parameters
LiJuan Yang et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2012)
IL-6, IL-17 and STAT3: a holy trinity in auto-immunity?
Annalisa Camporeale et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
Th17 cells in cancer: help or hindrance?
Cailin Moira Wilke et al.
CARCINOGENESIS (2011)
Functional Specialization of Interleukin-17 Family Members
Yoichiro Iwakura et al.
IMMUNITY (2011)
Distribution and Clinical Significance of Th17 Cells in the Tumor Microenvironment and Peripheral Blood of Pancreatic Cancer Patients
Songbing He et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2011)
Global quantification of mammalian gene expression control
Bjoern Schwanhaeusser et al.
NATURE (2011)
Dangerous liaisons: STAT3 and NF-κB collaboration and crosstalk in cancer
Sergei I. Grivennikov et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2010)
IL-6: Regulator of Treg/Th17 balance
Akihiro Kimura et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
Morphine Disrupts Interleukin-23 (IL-23)/IL-17-Mediated Pulmonary Mucosal Host Defense against Streptococcus pneumoniae Infection
Jing Ma et al.
INFECTION AND IMMUNITY (2010)
STAT3 in CD4+ T helper cell differentiation and inflammatory diseases
Charles E. Egwuagu
CYTOKINE (2009)
IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway
Lin Wang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Increased intratumoral IL-17-producing cells survival in hepatocellular carcinoma correlate with poor patients
Jing-Ping Zhang et al.
JOURNAL OF HEPATOLOGY (2009)
Constitutive activation of signal transducer and activator of transcription 3 in epithelial ovarian carcinoma
Hao Min et al.
JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (2009)
A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses
Shaoguang Wu et al.
NATURE MEDICINE (2009)
The prevalence of Th17 cells in patients with gastric cancer
Bin Zhang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Interleukin-17 Promotes Autoimmunity by Triggering a Positive-Feedback Loop via Interleukin-6 Induction
Hideki Ogura et al.
IMMUNITY (2008)
IL-23/IL-17 biology and therapeutic considerations
Chen Dong
JOURNAL OF IMMUNOTOXICOLOGY (2008)
Generation and regulation of human CD4+ IL-17-producing T cells in ovarian cancer
Yoshihiro Miyahara et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Role of STAT3 in CD4+CD25+FOXP3+ regulatory lymphocyte generation:: Implications in graft-versus-host disease and antitumor immunity
Jean-Rene Pallandre et al.
JOURNAL OF IMMUNOLOGY (2007)
Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation
Arian Laurence et al.
IMMUNITY (2007)
Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment
Hua Yu et al.
NATURE REVIEWS IMMUNOLOGY (2007)
IL-17 production is dominated by γδ T cells rather than CD4 T cells during Mycobacterium tuberculosis infection
Euan Lockhart et al.
JOURNAL OF IMMUNOLOGY (2006)
IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo
Emmanuel Zorn et al.
BLOOD (2006)
Signal transducers and activators of transcription 3 pathway activation in drug-resistant ovarian cancer
Zhenfeng Duan et al.
CLINICAL CANCER RESEARCH (2006)
VEGF, VEGFRs expressions and activated STATs in ovarian epithelial carcinoma
HZ Chen et al.
GYNECOLOGIC ONCOLOGY (2004)
分享论文
